NAAXIA COLL 30FL 0,4ML 1D 4,9%

NAAXIA 49 MG/ML COLLECTION - MONODOSE

active ingredients

1 ml of colliery, solution contains: Active ingredient: N-acetylaspartil-glutamic acid (sodium salt) 49 mg (or spaglumic acid). For the full list of excipients, see paragraph 6.1.

Excellent

Hydrochloric acid or hydroxide sodium q.b. pH 7,2; water for injectable preparations q.b. 1 ml.

Therapeutic indications

Conjunctivitis and kerato-conjunctivitis of allergic, acute and chronic nature. Spring conjunctivities.

Contraindications

Hypersensitivity to any of the components of Naaxia collirio, solution in monodose containers.

Population

Adults and children Instill in the joint sack of each eye, slightly pulling the lower eyelid down and looking up, a drop of Naaxia collirio solution 4 times a day. In seasonal forms, in order to obtain a good therapeutic outcome, it is recommended to start therapy a few days before the appearance of symptoms and continue treatment for the entire period established by the doctor, even in the absence of symptoms. To use only once Methods of administration The patient must be instructed to: • thoroughly wash your hands before and after instillation, • avoid touching the eye or eyelids with the end of the container, • use the colliery solution immediately after the first opening of the monodose container and hide the monodose after use.

Conservation

Store at a temperature not exceeding 25°C.

Warnings

The repeated use of the product can give rise to phenomena of hypersensitivity. After the first opening of the bottle, the residual product should not be reused. _ VOLTA. Keep out of reach of children.

Interactions

Special interactions or incompatibility with other drugs are not known at the moment. In case of contemporary treatment with other collieries, wait 15 minutes between instillation and the other.

Effects

Naaxia collirio solution, occasionally, can give rise to phenomena of hypersensitivity. Possible transitory burning or puncture sensation after instillation.

Overdosing

An overdose for eye instillation is unlikely because any excess solution would quickly be expelled from the joint sack. There is no risk of undesirable effects due to the accidental oral ingestion of Naaxia collirio solution, since, even the intake of the content of an entire package (0.4 ml x 30) contains a quantity of active ingredient largely below doses capable of producing toxic effects.

From studies carried out in the animal no toxic effect has emerged from spaglumic acid, sodium salt, pregnancy and the product of conception. As with all medicines, during the first trimester of pregnancy, as well as during breastfeeding, limit its use to the cases of actual need and under the direct control of the doctor.

Source: Farmadati